{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:18:13Z","timestamp":1783973893218,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Ministry of Health & Welfare, Republic of Korea","award":["RS-2023-KH140182"],"award-info":[{"award-number":["RS-2023-KH140182"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Accurate LN examination is critical for staging and prognosis in pancreatic cancer. However, the ideal number of LNs required for precise staging and improved survival remains unclear. This study aimed to determine the optimal number of lymph nodes (LNs) to retrieve during pancreatectomy for pancreatic cancer to minimize false node-negative (false N0) rates and assess its impact on survival outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective cohort study analyzed data from patients undergoing curative-intent upfront surgery for pancreatic cancer at two tertiary centers in South Korea (2010\u20132021). An exploration cohort of 808 patients was used to identify LN retrieval thresholds, and the results were validated in an independent cohort of 444 patients. The study excluded patients who received neoadjuvant therapy or had fewer than two retrieved LNs. False N0 rates and 5\u00a0year overall survival were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the exploration cohort, examining 16 LNs reduced the false N0 rate to 18.9%, whereas in the validation cohort, retrieving 12 LNs resulted in a false N0 rate of 19.5%. Among the node-negative (N0) patients, retrieving up to 21 LNs was associated with improved 5\u00a0year overall survival. Differences in cutoff values between cohorts were attributed to demographic variations and inclusion of fewer LNs retrieved but higher detection of metastatic nodes in the validation cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Retrieving a sufficient number of LNs during pancreatectomy is essential to reducing false N0 rates and improving survival outcomes for pancreatic cancer patients. These findings highlight the need for standardized LN evaluation protocols and support further prospective, multi-center studies to optimize staging accuracy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-18029-7","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T18:24:22Z","timestamp":1755973462000},"page":"8894-8902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimal Number of Lymph Nodes Retrieved to Lower the Risk of False N0 for Patients with Pancreatic Cancer Undergoing Curative Surgery"],"prefix":"10.1245","volume":"32","author":[{"given":"So Jeong","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Soo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Woong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Kyoung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbeom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"18029_CR1","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s11605-007-0243-7","volume":"11","author":"MG House","year":"2007","unstructured":"House MG, Gonen M, Jarnagin WR, et al. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg. 2007;11:1549\u201355. https:\/\/doi.org\/10.1007\/s11605-007-0243-7.","journal-title":"J Gastrointest Surg."},{"key":"18029_CR2","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1186\/s12885-019-6193-0","volume":"19","author":"MS You","year":"2019","unstructured":"You MS, Lee SH, Choi YH, et al. Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment. BMC Cancer. 2019;19:952. https:\/\/doi.org\/10.1186\/s12885-019-6193-0.","journal-title":"BMC Cancer."},{"key":"18029_CR3","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Pancreatic Adenocarcinoma V.3.2024. Retrieved 1 December 1 2024 at https:\/\/www.nccn.org\/Guidelines\/Guidelines-Detail?Category=1&Id=1455."},{"key":"18029_CR4","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1097\/sla.0000000000003558","volume":"274","author":"L Huang","year":"2021","unstructured":"Huang L, Jansen L, Balavarca Y, et al. Significance of examined lymph node number in accurate staging and long-term survival in resected stage I-II pancreatic cancer\u2013more is better? A large international population-based cohort study. Ann Surg. 2021;274:e554\u201363. https:\/\/doi.org\/10.1097\/sla.0000000000003558.","journal-title":"Ann Surg."},{"key":"18029_CR5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s11605-012-1853-2","volume":"16","author":"M Huebner","year":"2012","unstructured":"Huebner M, Kendrick M, Reid-Lombardo KM, et al. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16:920\u20136. https:\/\/doi.org\/10.1007\/s11605-012-1853-2.","journal-title":"J Gastrointest Surg."},{"key":"18029_CR6","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge S, Greene F, et al. AJCC cancer staging manual. 8th edn. New York: Springer International Publishing; 2017.","edition":"8"},{"key":"18029_CR7","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.1200\/jco.2009.23.7958","volume":"27","author":"M G\u00f6nen","year":"2009","unstructured":"G\u00f6nen M, Schrag D, Weiser MR. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol. 2009;27:6166\u201371. https:\/\/doi.org\/10.1200\/jco.2009.23.7958.","journal-title":"J Clin Oncol."},{"key":"18029_CR8","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1200\/jco.2016.67.6437","volume":"34","author":"TJ Robinson","year":"2016","unstructured":"Robinson TJ, Thomas S, Dinan MA, Roman S, Sosa JA, Hyslop T. How many lymph nodes are enough? Assessing the adequacy of lymph node yield for papillary thyroid cancer. J Clin Oncol. 2016;34:3434\u20139. https:\/\/doi.org\/10.1200\/jco.2016.67.6437.","journal-title":"J Clin Oncol."},{"key":"18029_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1053\/j.gastro.2024.05.028","volume":"167","author":"CS Leonhardt","year":"2024","unstructured":"Leonhardt CS, Gustorff C, Klaiber U, et al. Prognostic factors for early recurrence after resection of pancreatic cancer: a systematic review and meta-analysis. Gastroenterology. 2024;167:977\u201392. https:\/\/doi.org\/10.1053\/j.gastro.2024.05.028.","journal-title":"Gastroenterology."},{"key":"18029_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jhbp.815","volume":"28","author":"SJ Yoon","year":"2021","unstructured":"Yoon SJ, Shin SH, Yoon SK, et al. Appraisal of 5-year recurrence-free survival after surgery in pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2021;28:287\u201396. https:\/\/doi.org\/10.1002\/jhbp.815.","journal-title":"J Hepatobiliary Pancreat Sci."},{"key":"18029_CR11","doi-asserted-by":"publisher","first-page":"107327482091594","DOI":"10.1177\/1073274820915947","volume":"27","author":"C Liu","year":"2020","unstructured":"Liu C, Cheng H, Jin K, et al. Resected pancreatic cancer with N2 node involvement is refractory to gemcitabine-based adjuvant chemotherapy. Cancer Control. 2020;27:1073274820915947. https:\/\/doi.org\/10.1177\/1073274820915947.","journal-title":"Cancer Control."},{"key":"18029_CR12","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379:2395\u2013406. https:\/\/doi.org\/10.1056\/NEJMoa1809775.","journal-title":"N Engl J Med."},{"key":"18029_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pan.2015.03.012","volume":"15","author":"Z Liu","year":"2015","unstructured":"Liu Z, Luo G, Guo M, et al. Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer. Pancreatology. 2015;15:253\u20138. https:\/\/doi.org\/10.1016\/j.pan.2015.03.012.","journal-title":"Pancreatology."},{"key":"18029_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.surg.2014.06.016","volume":"156","author":"JA Tol","year":"2014","unstructured":"Tol JA, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery. 2014;156:591\u2013600. https:\/\/doi.org\/10.1016\/j.surg.2014.06.016.","journal-title":"Surgery."},{"key":"18029_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jamcollsurg.2018.12.031","volume":"228","author":"AK Arrington","year":"2019","unstructured":"Arrington AK, Price ET, Golisch K, Riall TS. Pancreatic cancer lymph node resection revisited: a novel calculation of number of lymph nodes required. J Am Coll Surg. 2019;228:662\u20139. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2018.12.031.","journal-title":"J Am Coll Surg."},{"key":"18029_CR16","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.ejso.2019.01.018","volume":"45","author":"J Hua","year":"2019","unstructured":"Hua J, Zhang B, Xu J, et al. Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: an analysis using the nodal staging score model. Eur J Surg Oncol. 2019;45:1069\u201376. https:\/\/doi.org\/10.1016\/j.ejso.2019.01.018.","journal-title":"Eur J Surg Oncol."},{"key":"18029_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1245\/s10434-007-9587-1","volume":"15","author":"MB Slidell","year":"2008","unstructured":"Slidell MB, Chang DC, Cameron JL, et al. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol. 2008;15:165\u201374. https:\/\/doi.org\/10.1245\/s10434-007-9587-1.","journal-title":"Ann Surg Oncol."},{"key":"18029_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1245\/s10434-006-9016-x","volume":"13","author":"RE Schwarz","year":"2006","unstructured":"Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol. 2006;13:1189\u2013200. https:\/\/doi.org\/10.1245\/s10434-006-9016-x.","journal-title":"Ann Surg Oncol."},{"key":"18029_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.amjsurg.2017.06.036","volume":"214","author":"CM Contreras","year":"2017","unstructured":"Contreras CM, Lin CP, Oster RA, et al. Increased pancreatic cancer survival with greater lymph node retrieval in the National Cancer Data Base. Am J Surg. 2017;214:442\u20139. https:\/\/doi.org\/10.1016\/j.amjsurg.2017.06.036.","journal-title":"Am J Surg."},{"key":"18029_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MPA.0b013e31816074c9","volume":"37","author":"M Hellan","year":"2008","unstructured":"Hellan M, Sun CL, Artinyan A, et al. The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer. Pancreas. 2008;37:19\u201324. https:\/\/doi.org\/10.1097\/MPA.0b013e31816074c9.","journal-title":"Pancreas."},{"key":"18029_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071834","volume":"14","author":"D Prassas","year":"2022","unstructured":"Prassas D, Safi SA, Stylianidi MC, et al. N, LNR or LODDS: Which is the most appropriate lymph node classification scheme for patients with radically resected pancreatic cancer? Cancers Basel. 2022;14:1834. https:\/\/doi.org\/10.3390\/cancers14071834.","journal-title":"Cancers Basel."},{"key":"18029_CR22","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/bjs.10472","volume":"104","author":"I Tarantino","year":"2017","unstructured":"Tarantino I, Warschkow R, Hackert T, et al. Staging of pancreatic cancer based on the number of positive lymph nodes. Br J Surg. 2017;104:608\u201318. https:\/\/doi.org\/10.1002\/bjs.10472.","journal-title":"Br J Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18029-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18029-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18029-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:41:31Z","timestamp":1760715691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18029-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["18029"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18029-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}